Welcome to the Clara Nahmias’ lab Homepage
Clara Nahmias team is interested in studying cell-cell communication in normal and pathological situations, with a particular focus on the role of the angiotensin/ATIP axis and the microtubule cytoskeleton in breast cancer.
Seminal work of the team identified a novel family of proteins (ATIPs) initially isolated as interacting partners of the AT2 receptor. Recent studies led to the discovery that ATIP3 is a new anti-cancer molecule and a promising target for personalized therapies of aggressive breast cancer.
This studies were recently highlighted in the Inserm Website:
"Breast Cancer: a protein prevents metastasis" > Read
Scientific news > Read
Projects of the team are supported by grants from the CNRS, Inserm, Gustave Roussy Institute, Roche laboratories, the Ligue Contre le Cancer, the association Le cancer du sein, parlons-en !, the fondation RAJA-Marcovici, the association Odyssea and the association Prolific.
Clara Nahmias Interview
Presentation of the ATIP3 project by Clara Nahmias